Athina Pappas1, Douglas E Kendrick2, Seetha Shankaran1, Barbara J Stoll3, Edward F Bell4, Abbott R Laptook5, Michele C Walsh3, Abhik Das6, Ellen C Hale3, Nancy S Newman7, Rosemary D Higgins8. 1. Department of Pediatrics, Wayne State University, Detroit, Michigan. 2. Social, Statistical, and Environmental Sciences Unit, RTI International, Research Triangle Park, North Carolina. 3. Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia. 4. Department of Pediatrics, University of Iowa, Iowa City. 5. Department of Pediatrics, Women & Infants' Hospital, Brown University, Providence, Rhode Island. 6. Social, Statistical, and Environmental Sciences Unit, RTI International, Rockville, Maryland. 7. Department of Pediatrics, Rainbow Babies & Children's Hospital, Case Western Reserve University, Cleveland, Ohio. 8. Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland.
Abstract
IMPORTANCE: Chorioamnionitis is strongly linked to preterm birth and neonatal infection. The association between histological and clinical chorioamnionitis and cognitive, behavioral, and neurodevelopmental outcomes among extremely preterm neonates is less clear. We evaluated the impact of chorioamnionitis on 18- to 22-month neurodevelopmental outcomes in a contemporary cohort of extremely preterm neonates. OBJECTIVE: To compare the neonatal and neurodevelopmental outcomes of 3 groups of extremely low-gestational-age infants with increasing exposure to perinatal inflammation: no chorioamnionitis, histological chorioamnionitis alone, or histological plus clinical chorioamnionitis. DESIGN, SETTING, AND PARTICIPANTS: Longitudinal observational study at 16 centers of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Two thousand three hundred ninety extremely preterm infants born at less than 27 weeks' gestational age (GA) between January 1, 2006, and December 31, 2008, with placental histopathology and 18 to 22 months' corrected age follow-up data were eligible. MAIN EXPOSURE: Chorioamnionitis. MAIN OUTCOMES AND MEASURES: Outcomes included cerebral palsy, gross motor functional limitation, behavioral scores (according to the Brief Infant-Toddler Social and Emotional Assessment), cognitive and language scores (according to the Bayley Scales of Infant and Toddler Development, Third Edition), and composite measures of death/neurodevelopmental impairment. Multivariable logistic and linear regression models were developed to assess the association between chorioamnionitis and outcomes while controlling for important variables known at birth. RESULTS: Neonates exposed to chorioamnionitis had a lower GA and higher rates of early-onset sepsis and severe periventricular-intraventricular hemorrhage as compared with unexposed neonates. In multivariable models evaluating death and neurodevelopmental outcomes, inclusion of GA in the model diminished the association between chorioamnionitis and adverse outcomes. Still, histological plus clinical chorioamnionitis was associated with increased risk of cognitive impairment as compared with no chorioamnionitis (adjusted odds ratio [OR], 2.38 [95% CI, 1.32 to 4.28] without GA; adjusted OR, 2.00 [95% CI, 1.10 to 3.64] with GA as a covariate). Histological chorioamnionitis alone was associated with lower odds of death/neurodevelopmental impairment as compared with histological plus clinical chorioamnionitis (adjusted OR, 0.68 [95% CI, 0.52 to 0.89] without GA; adjusted OR, 0.66 [95% CI, 0.49 to 0.89] with GA as a covariate). Risk of behavioral problems did not differ statistically between groups. CONCLUSIONS AND RELEVANCE: Antenatal exposure to chorioamnionitis is associated with altered odds of cognitive impairment and death/neurodevelopmental impairment in extremely preterm infants.
IMPORTANCE: Chorioamnionitis is strongly linked to preterm birth and neonatal infection. The association between histological and clinical chorioamnionitis and cognitive, behavioral, and neurodevelopmental outcomes among extremely preterm neonates is less clear. We evaluated the impact of chorioamnionitis on 18- to 22-month neurodevelopmental outcomes in a contemporary cohort of extremely preterm neonates. OBJECTIVE: To compare the neonatal and neurodevelopmental outcomes of 3 groups of extremely low-gestational-age infants with increasing exposure to perinatal inflammation: no chorioamnionitis, histological chorioamnionitis alone, or histological plus clinical chorioamnionitis. DESIGN, SETTING, AND PARTICIPANTS: Longitudinal observational study at 16 centers of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Two thousand three hundred ninety extremely preterm infants born at less than 27 weeks' gestational age (GA) between January 1, 2006, and December 31, 2008, with placental histopathology and 18 to 22 months' corrected age follow-up data were eligible. MAIN EXPOSURE: Chorioamnionitis. MAIN OUTCOMES AND MEASURES: Outcomes included cerebral palsy, gross motor functional limitation, behavioral scores (according to the Brief Infant-Toddler Social and Emotional Assessment), cognitive and language scores (according to the Bayley Scales of Infant and Toddler Development, Third Edition), and composite measures of death/neurodevelopmental impairment. Multivariable logistic and linear regression models were developed to assess the association between chorioamnionitis and outcomes while controlling for important variables known at birth. RESULTS: Neonates exposed to chorioamnionitis had a lower GA and higher rates of early-onset sepsis and severe periventricular-intraventricular hemorrhage as compared with unexposed neonates. In multivariable models evaluating death and neurodevelopmental outcomes, inclusion of GA in the model diminished the association between chorioamnionitis and adverse outcomes. Still, histological plus clinical chorioamnionitis was associated with increased risk of cognitive impairment as compared with no chorioamnionitis (adjusted odds ratio [OR], 2.38 [95% CI, 1.32 to 4.28] without GA; adjusted OR, 2.00 [95% CI, 1.10 to 3.64] with GA as a covariate). Histological chorioamnionitis alone was associated with lower odds of death/neurodevelopmental impairment as compared with histological plus clinical chorioamnionitis (adjusted OR, 0.68 [95% CI, 0.52 to 0.89] without GA; adjusted OR, 0.66 [95% CI, 0.49 to 0.89] with GA as a covariate). Risk of behavioral problems did not differ statistically between groups. CONCLUSIONS AND RELEVANCE: Antenatal exposure to chorioamnionitis is associated with altered odds of cognitive impairment and death/neurodevelopmental impairment in extremely preterm infants.
Authors: Andrea Freeman Duncan; Kristi L Watterberg; Tracy L Nolen; Betty R Vohr; Ira Adams-Chapman; Abhik Das; Jean Lowe Journal: J Pediatr Date: 2012-01-23 Impact factor: 4.406
Authors: R Bordet; D Deplanque; P Maboudou; F Puisieux; Q Pu; E Robin; A Martin; M Bastide; D Leys; M Lhermitte; B Dupuis Journal: J Cereb Blood Flow Metab Date: 2000-08 Impact factor: 6.200
Authors: Ashutosh Chaudhry; Dipayan Rudra; Piper Treuting; Robert M Samstein; Yuqiong Liang; Arnold Kas; Alexander Y Rudensky Journal: Science Date: 2009-10-01 Impact factor: 47.728
Authors: Athina Pappas; Ira Adams-Chapman; Seetha Shankaran; Scott A McDonald; Barbara J Stoll; Abbot R Laptook; Waldemar A Carlo; Krisa P Van Meurs; Susan R Hintz; Martha D Carlson; Jane E Brumbaugh; Michele C Walsh; Myra H Wyckoff; Abhik Das; Rosemary D Higgins Journal: JAMA Pediatr Date: 2018-01-01 Impact factor: 16.193
Authors: Robert L Schelonka; Waldemar A Carlo; Charles R Bauer; Myriam Peralta-Carcelen; Vivien Phillips; Jennifer Helderman; Christina T Navarrete; J Randall Moorman; Douglas E Lake; John Kattwinkel; Karen D Fairchild; T Michael O'Shea Journal: J Pediatr Date: 2020-02-04 Impact factor: 4.406